MQF 2024 Inaugural US Fellows

The MQ Foundation selected its inaugural cohort of three 2024 Fellows whose research will address suicidality, post-traumatic stress symptoms and anxiety to advance diagnosis, prevention and treatment.  Fellows receive funding, mentorship and access to experts and those with lived experience.  Fellows’ research will commence in Winter 2025.

The Fellow Awards support early career researchers launching independent research and investigating questions for improved patient mental health outcomes.  The call was open to U.S. researchers from all disciplines related to mental health and all mental health conditions. Research could be based in the laboratory, clinic or field and could involve theoretical, experimental, social science or medical humanities approaches. The three-stage selection process involved rigorous application review by staff, the Research Committee and external peer reviewers, and interviews by the Committee and public/patient representatives, as well as input from the Lived Experience Expert Network.  

MQ Fellows Award 

MQF is seeking partners to fund Fellow Awards, each of which is $375,000 over three-years. 

Please contact Ann Richman, Executive Director at arichman@mqfoundation.org, with any questions or for additional information about recognition opportunities and how to collaborate with MQF.

PAST US MQ Fellows

  • Dr Susanne Ahmar

    identified brain activity related to Obsessive behaviors, the first step towards developing new treatments for OCD.

  • Dr Joshua Roffman

    found that by increasing the consumption of folic acid during pregnancy, changes occur in children’s brain development, thus reducing the incidence of psychotic symptoms in later life.

  • Dr Jeremiah Cohen

    used innovative techniques to explore the role that brain chemical serotonin plays in affecting mood which will lead to better drugs to treat mood disorders in the future.

  • Professor Sergiu Pasca

    developed a method to create 3D brain circuits ‘in a dish’, providing a pioneering new way to understand how different parts of the brain develop.

  • Dr Ian Maze

    took a novel, multi-disciplinary approach to understanding how serotonin impacts major depressive disorder which could lead to improved pharmacological treatments for depression.

  • Professor Jean-Baptiste Pingault

    found strong evidence around the direct impact of bullying on the development of mental health problems in young people.

  • Dr Patrick Rothwell

    identified the brain cells related to impulse control which could lead to the development of treatments to curb negative behaviors.

  • Dr Marisa Marraccini

    is co-designing a virtual reality tool to help adolescents who have been hospitalised for suicide-related crisis.

  • Dr Leslie Johnson

    is adapting and testing an existing treatment for people with type 2 diabetes in order to treat patients with type 1 diabetes.

  • Dr Alexandre Lussier

    is running a longitudinal study of gene-environment interactions and epigenetic mechanisms to understand how depressive disorders influence suicide risk.